Scholars Central

EditorialPublished 29 Jul 2025

Immune Checkpoint Blockade: Evolving Biomarker Landscape

Authors: Lucas Ferreira

São Paulo Institute of Oncology, Brazil

Journal of Cancer Diagnosis

Volume 9 · Issue 4 · Pages 1–4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Predictive and prognostic biomarkers are vital for immune checkpoint blockade in solid tumors. Established markers include PD-L1 expression, \textit{Tumor Mutational Burden} (TMB), and Microsatellite Instability (MSI), guiding personalized treatment. Understanding mechanisms of response and resistance is key. Emerging biomarkers like tumor microenvironment features, gut mi crobiome characteristics, and specific gene signatures offer new insights. Non-invasive liquid biopsies, detecting circulating tumor DNA(ctDNA)andcells,providereal-timeinformation ontumorevolution andresponse. Proteomicanalysis further enhances predic tion by revealing complex biological pathways. These diverse biomarkers are crucial for optimizing patient selection and improving immunotherapy outcomes.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Cancer Diagnosis.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cancer Diagnosis
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Lucas Ferreira”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels